| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Radiology, Vol 203, 323-327, Copyright © 1997 by Radiological Society of North America
ARTICLES |
LP Adler, PF Faulhaber, KC Schnur, NL Al-Kasi and RR Shenk
Department of Radiology, University Hospitals of Cleveland, OH 44106, USA.
PURPOSE: To evaluate [fluorine-18]2-deoxy-2-fluoro-D-glucose (FDG) positron emission tomography (PET) of the axilla as a screening test for detecting regional spread of breast cancer. MATERIALS AND METHODS: High-dose FDG PET of the axilla was successfully performed in 50 patients (age range, 36-79 years) with breast cancer before 52 axillary lymph node dissections. Two additional patients had scans that were uninterpretable because of intense myocardial activity that obscured the axilla. RESULTS: The sensitivity and negative predictive value were both 95%, the specificity was 66%, and the overall accuracy was 77%. The only false-negative PET scan was obtained in the largest patient, who had a low-quality scan. CONCLUSION: Patients with negative PET scans had such a low risk for axillary lymph node metastases that axillary dissection was not warranted. Patients with positive PET scans required dissection to confirm the presence and determine the number of positive lymph nodes. Had this algorithm been used to select patients for dissection, approximately $120,000 in charges ($2,300 per patient) would have been saved and 22 patients would have been spared the morbidity of axillary lymph node dissection. Within this study population, PET scans of the axilla were interpreted with sufficient sensitivity for PET to serve as a cost-effective screening test for axillary lymph node metastases.
This article has been cited by other articles:
|
|
 |
|
  N. Taira, S. Ohsumi, D. Takabatake, F. Hara, S. Takashima, K. Aogi, S. Takashima, T. Inoue, S. Sugata, and R. Nishimura Determination of Indication for Sentinel Lymph Node Biopsy in Clinical Node-negative Breast Cancer Using Preoperative 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging Jpn. J. Clin. Oncol., January 1, 2009; 39(1): 16 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gillies, I. Robey, and R. A. Gatenby Causes and Consequences of Increased Glucose Metabolism of Cancers J. Nucl. Med., June 1, 2008; 49(Suppl_2): 24S - 42S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U Veronesi, C De Cicco, V. Galimberti, J. Fernandez, N Rotmensz, G Viale, G Spano, A Luini, M Intra, P Veronesi, et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases Ann. Onc., March 1, 2007; 18(3): 473 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Blodgett, C. C. Meltzer, and D. W. Townsend PET/CT: Form and Function Radiology, February 1, 2007; 242(2): 360 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Quon and S. S. Gambhir FDG-PET and Beyond: Molecular Breast Cancer Imaging J. Clin. Oncol., March 10, 2005; 23(8): 1664 - 1673. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Lovrics, V. Chen, G. Coates, S. D. Cornacchi, C. H. Goldsmith, C. Law, M. N. Levine, K. Sanders, and V. R. Tandan A Prospective Evaluation of Positron Emission Tomography Scanning, Sentinel Lymph Node Biopsy, and Standard Axillary Dissection for Axillary Staging in Patients with Early Stage Breast Cancer Ann. Surg. Oncol., September 1, 2004; 11(9): 846 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J.M. van der Hoeven, N. C. Krak, O. S. Hoekstra, E. F.I. Comans, R. P.A. Boom, D. van Geldere, S. Meijer, E. van der Wall, J. Buter, H. M. Pinedo, et al. 18F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Staging of Locally Advanced Breast Cancer J. Clin. Oncol., April 1, 2004; 22(7): 1253 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Wahl, B. A. Siegel, R. E. Coleman, and C. G. Gatsonis Prospective Multicenter Study of Axillary Nodal Staging by Positron Emission Tomography in Breast Cancer: A Report of the Staging Breast Cancer With PET Study Group J. Clin. Oncol., January 15, 2004; 22(2): 277 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Guller, E. Nitzsche, H. Moch, and M. Zuber Is Positron Emission Tomography an Accurate Non-invasive Alternative to Sentinel Lymph Node Biopsy in Breast Cancer Patients? J Natl Cancer Inst, July 16, 2003; 95(14): 1040 - 1043. [Full Text] [PDF]
|
|
|
|
|
|
E. Barranger, D. Grahek, M. Antoine, F. Montravers, J.-N. Talbot, and S. Uzan Evaluation of Fluorodeoxyglucose Positron Emission Tomography in the Detection of Axillary Lymph Node Metastases in Patients With Early-Stage Breast Cancer Ann. Surg. Oncol., July 1, 2003; 10(6): 622 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Kostakoglu, H. Agress Jr, and S. J. Goldsmith Clinical Role of FDG PET in Evaluation of Cancer Patients RadioGraphics, March 1, 2003; 23(2): 315 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Rieber, H Schirrmeister, A Gabelmann, K Nuessle, S Reske, R Kreienberg, H J Brambs, and T Kuehn Pre-operative staging of invasive breast cancer with MR mammography and/or PET: boon or bunk? Br. J. Radiol., October 1, 2002; 75(898): 789 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A D Murray, R T Staff, T W Redpath, F J Gilbert, A K Ah-See, J A Brookes, I D Miller, and S Payne Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes Br. J. Radiol., March 1, 2002; 75(891): 220 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. Yang, C. Metreweli, P. K. W. Lam, and J. Chang Benign and Malignant Breast Masses and Axillary Nodes: Evaluation with Echo-enhanced Color Power Doppler US Radiology, September 1, 2001; 220(3): 795 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. B. Eubank, D. A. Mankoff, J. Takasugi, H. Vesselle, J. F. Eary, T. J. Shanley, J. R. Gralow, A. Charlop, G. K. Ellis, K. L. Lindsley, et al. 18Fluorodeoxyglucose Positron Emission Tomography to Detect Mediastinal or Internal Mammary Metastases in Breast Cancer J. Clin. Oncol., August 1, 2001; 19(15): 3516 - 3523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF]
|
|
|
|
|
|
M. Greco, F. Crippa, R. Agresti, E. Seregni, A. Gerali, R. Giovanazzi, A. Micheli, S. Asero, C. Ferraris, M. Gennaro, et al. Axillary Lymph Node Staging in Breast Cancer by 2-Fluoro-2-deoxy-D-glucose-Positron Emission Tomography: Clinical Evaluation and Alternative Management J Natl Cancer Inst, April 18, 2001; 93(8): 630 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Messa, C. Landoni, C. Pozzato, and F. Fazio Is There a Role for FDG PET in the Diagnosis of Musculoskeletal Neoplasms? J. Nucl. Med., October 1, 2000; 41(10): 1702 - 1702. [Full Text] [PDF]
|
|
|
|
|
|
P. G. Rose, L. P. Adler, M. Rodriguez, P. F. Faulhaber, F. W. Abdul-Karim, and F. Miraldi Positron Emission Tomography for Evaluating Para-aortic Nodal Metastasis in Locally Advanced Cervical Cancer Before Surgical Staging: A Surgicopathologic Study J. Clin. Oncol., January 1, 1999; 17(1): 41 - 41. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
